Authors:
Tognoni, A
Pensa, F
Vaira, F
Vigani, A
Bancalari, L
Fiasella, L
Maggiani, R
Canessa, P
Pronzato, P
Citation: A. Tognoni et al., A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer, J CHEMOTHER, 13(2), 2001, pp. 202-205
Authors:
Del Mastro, L
Venturini, M
Lionetto, R
Carnino, F
Guarneri, D
Gallo, L
Contu, A
Pronzato, P
Vesentini, L
Bergaglio, M
Comis, S
Rosso, R
Citation: L. Del Mastro et al., Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group, J CL ONCOL, 19(8), 2001, pp. 2213-2221
Authors:
Pronzato, P
Queirolo, P
Vecchio, S
Lionetto, R
Del Mastro, L
Venturini, M
Gardin, G
Alama, A
Sertoli, MR
Citation: P. Pronzato et al., Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy, ONCOL-BASEL, 60(1), 2001, pp. 88-93
Authors:
Vigani, A
Pensa, F
Vaira, F
Bancalari, L
Cordani, S
Maggiani, R
Canessa, P
Pronzato, P
Citation: A. Vigani et al., Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer., ANTICANC R, 20(5C), 2000, pp. 4015-4018
Authors:
Venturino, A
Comandini, D
Simoni, C
Merlini, L
Naso, C
Palumbo, R
Fusco, V
Porcile, G
Pronzato, P
Rosso, R
Repetto, L
Citation: A. Venturino et al., Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin, BREAST CANC, 60(3), 2000, pp. 195-200
Authors:
Tognoni, A
Cadenotti, L
Pensa, F
Vaira, F
Vigani, A
Bancalari, L
Cordani, S
Maggiani, R
Canessa, PA
Pronzato, P
Citation: A. Tognoni et al., A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non smallcell lung cancer, J CHEMOTHER, 11(4), 1999, pp. 306-309